PRVA Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$31.89median target· current $23.67 (+34.7%)20 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio139.24Forward 26.04
EPS (TTM)$0.17-33.3% YoY
Profit margin1.0%HEALTHCARE
Market cap$2.98BMid cap
Valuation
- Forward P/E
- 26.04
- PEG ratio
- —
- P/B
- 3.96
- P/S (TTM)
- 1.33
- EV/EBITDA
- 53.90
Profitability & growth
- ROE (TTM)
- 3.6%
- Operating margin
- 1.2%
- Revenue growth YoY
- 25.8%
- Dividend yield
- —
- Beta
- 0.84
Last earnings
May 7, 2026 · Estimate $0.25 · Reported $0.19
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Privia Health Group Inc
Company profilePrivia Health Group, Inc. is a population health technology and medical practice management company in the United States.
Classification
- Sector
- Healthcare
- Industry
- Health Information Services
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 950 NORTH GLEBE ROAD, ARLINGTON, VA
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
Market cap$2.98B
Shares outstanding$126.0M
52W high$28.82
52W low$19.08
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent